Restart Life Sciences Corp. (NMLSF)

Revance Therapeutics Statistics

Total Valuation

NMLSF has a market cap or net worth of 2.62 million. The enterprise value is 2.34 million.

Market Cap	2.62M
Enterprise Value	2.34M

Important Dates

The next estimated earnings date is Wednesday, August 27, 2025.

Earnings Date	Aug 27, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	36.05M
Shares Outstanding	n/a
Shares Change (YoY)	+23.94%
Shares Change (QoQ)	+44.49%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	31.43M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	14.16
P/TBV Ratio	14.16
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-7.48
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.74

Current Ratio	2.74
Quick Ratio	2.74
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-318.32%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-434.78%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -32.24% in the last 52 weeks. The beta is -0.30, so NMLSF's price volatility has been lower than the market average.

Beta (5Y)	-0.30
52-Week Price Change	-32.24%
50-Day Moving Average	0.06
200-Day Moving Average	0.06
Relative Strength Index (RSI)	74.08
Average Volume (20 Days)	755

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-805,059
Pretax Income	-312,816
Net Income	-312,816
EBITDA	-803,535
EBIT	-805,059
Earnings Per Share (EPS)	-0.02

Balance Sheet

The company has 270,157 in cash and n/a in debt, giving a net cash position of 270,157.

Cash & Cash Equivalents	270,157
Total Debt	n/a
Net Cash	270,157
Net Cash Per Share	n/a
Equity (Book Value)	185,166
Book Value Per Share	0.01
Working Capital	179,173

Cash Flow

Operating Cash Flow	-181,413
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

NMLSF does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-23.94%
Shareholder Yield	n/a
Earnings Yield	-11.93%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on January 24, 2025. It was a reverse split with a ratio of 0.5.

Last Split Date	Jan 24, 2025
Split Type	Reverse
Split Ratio	0.5

Scores

Altman Z-Score	n/a
Piotroski F-Score	2